Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes LRK-4189 being studied for safety, tolerability, and preliminary efficacy in patients with solid tumors in Phase 1 and Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• LRK-4189

Snippet

Sponsor: LARKSPUR BIOSCIENCES, INC. | Conditions: Neoplasms | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING